By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ProMetic Life Sciences Inc. 

8168 Montview Road

Mount-Royal  Quebec  H4P 2L7  Canada
Phone: 514-341-2115 Fax: 514-341-6227




Company News
ProMetic Life Sci (PFSCF.PK) Reports Positive Clinical Data From Ongoing PBI-4050 Study In Alström Syndrome Patients 9/19/2017 6:40:17 AM
ProMetic Life Sci (PFSCF.PK) Receives Rare Pediatric Disease Designation From U.S. FDA For Its Plasminogen Replacement Therapy 8/29/2017 7:15:51 AM
ProMetic Life Sci (PFSCF.PK) Reports 2017 Second Quarter Highlights and Financial Results 8/15/2017 8:07:05 AM
ProMetic Life Sci (PFSCF.PK) And Shenzhen Royal Asset Management Close Transaction For Joint Venture And Licensing Rights To PBI-4050, PBI-4547 And PBI-4425 In China 8/14/2017 6:52:38 AM
ProMetic Life Sci (PFSCF.PK) To Report Its Second Quarter 2017 Financial Results And To Hold Conference Call / Webcast 8/8/2017 12:26:17 PM
ProMetic Life Sci (PFSCF.PK) Announces Positive Long Term Clinical Data On Ryplazym In Plasminogen Congenital Deficiency And Provides Regulatory Update 7/11/2017 6:52:56 AM
ProMetic Life Sci (PFSCF.PK) Announces Closing Of Equity Offerings For Aggregate Gross Proceeds Of $61.7 Million 7/6/2017 7:41:39 AM
ProMetic Life Sci (PFSCF.PK) Release: New Data Presented By Prometic At American Diabetes Association's Scientific Sessions Validates PBI-4050's Positive Impact On Kidneys In Patients With Diabetes And Metabolic Syndrome 6/12/2017 8:10:58 AM
ProMetic Life Sci (PFSCF.PK) Presents New Data On PBI-4050 And Plasminogen At American Thoracic Society's 2017 International Conference 5/23/2017 7:32:20 AM
ProMetic Life Sci (PFSCF.PK) Announces The Closing Of The $25 Million Follow-On Financing From Structured Alpha LP, An Affiliate Of Thomvest Asset Management Inc. 4/28/2017 8:44:55 AM